Page last updated: 2024-12-10

azaleatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azaleatin : A monomethoxyflavone that is quercetin in which the hydroxy group at position 5 is replaced by a methoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281604
CHEMBL ID470848
CHEBI ID2945
SCHEMBL ID890990

Synonyms (31)

Synonym
azaleatin
quercetin 5-methyl ether
529-51-1
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxy-
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxy-4h-1-benzopyran-4-one
5-o-methylquercetin
chebi:2945 ,
CHEMBL470848 ,
LMPK12112546
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxychromen-4-one
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxy-4h-chromen-4-one
bdbm50326483
unii-so52512d8g
so52512d8g ,
5-o-methyl quercetin
FT-0632310
SCHEMBL890990
5-methoxy-3,3',4',7-tetrahydroxyflavone
Q-100928
3,3',4',7-tetrahydroxy-5-methoxyflavone
DTXSID80200945
mfcd00017427
5-o-methylquercetinquercetin 5-methyl ether
o-methylquercetin, 5-
flavone, 3,3',4',7-tetrahydroxy-5-methoxy-
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-methoxy-4h-1-benzopyran-4-one 5-o-methylquercetin
Q2875086
MS-24650
CS-0134981
HY-N7653
AKOS040760285
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
7-hydroxyflavonolAny flavonol carrying a 7-hydroxy substituent.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
monomethoxyflavoneAny methoxyflavone with a single methoxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NADPH oxidase 4Homo sapiens (human)IC50 (µMol)0.74000.07080.87881.3400AID510244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
cell morphogenesisNADPH oxidase 4Homo sapiens (human)
heart processNADPH oxidase 4Homo sapiens (human)
superoxide metabolic processNADPH oxidase 4Homo sapiens (human)
inflammatory responseNADPH oxidase 4Homo sapiens (human)
negative regulation of cell population proliferationNADPH oxidase 4Homo sapiens (human)
gene expressionNADPH oxidase 4Homo sapiens (human)
superoxide anion generationNADPH oxidase 4Homo sapiens (human)
bone resorptionNADPH oxidase 4Homo sapiens (human)
homocysteine metabolic processNADPH oxidase 4Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionNADPH oxidase 4Homo sapiens (human)
cardiac muscle cell differentiationNADPH oxidase 4Homo sapiens (human)
positive regulation of protein tyrosine kinase activityNADPH oxidase 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeNADPH oxidase 4Homo sapiens (human)
cellular response to glucose stimulusNADPH oxidase 4Homo sapiens (human)
reactive oxygen species biosynthetic processNADPH oxidase 4Homo sapiens (human)
positive regulation of DNA biosynthetic processNADPH oxidase 4Homo sapiens (human)
defense responseNADPH oxidase 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
nucleotide bindingNADPH oxidase 4Homo sapiens (human)
protein bindingNADPH oxidase 4Homo sapiens (human)
electron transfer activityNADPH oxidase 4Homo sapiens (human)
NAD(P)H oxidase H2O2-forming activityNADPH oxidase 4Homo sapiens (human)
superoxide-generating NAD(P)H oxidase activityNADPH oxidase 4Homo sapiens (human)
oxygen sensor activityNADPH oxidase 4Homo sapiens (human)
heme bindingNADPH oxidase 4Homo sapiens (human)
flavin adenine dinucleotide bindingNADPH oxidase 4Homo sapiens (human)
modified amino acid bindingNADPH oxidase 4Homo sapiens (human)
superoxide-generating NADPH oxidase activityNADPH oxidase 4Homo sapiens (human)
NADPH oxidase H202-forming activityNADPH oxidase 4Homo sapiens (human)
protein tyrosine kinase bindingNADPH oxidase 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
nucleusNADPH oxidase 4Homo sapiens (human)
nucleolusNADPH oxidase 4Homo sapiens (human)
mitochondrionNADPH oxidase 4Homo sapiens (human)
endoplasmic reticulumNADPH oxidase 4Homo sapiens (human)
endoplasmic reticulum membraneNADPH oxidase 4Homo sapiens (human)
plasma membraneNADPH oxidase 4Homo sapiens (human)
focal adhesionNADPH oxidase 4Homo sapiens (human)
membraneNADPH oxidase 4Homo sapiens (human)
perinuclear region of cytoplasmNADPH oxidase 4Homo sapiens (human)
perinuclear endoplasmic reticulumNADPH oxidase 4Homo sapiens (human)
plasma membraneNADPH oxidase 4Homo sapiens (human)
NADPH oxidase complexNADPH oxidase 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID510246Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay substituted with 3 uM H2O22010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID353591Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID510245Cytotoxicity against human free style HEK293 cells after 72 hrs2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID353599Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID353590Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID666769Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1871813Anticoagulant activity in rabbit plasma assessed as prothrombin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID510244Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID666771Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1871811Anticoagulant activity in rabbit plasma assessed as thrombin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID1323133Antioxidant activity assessed as DPPH free radical scavenging activity at 5 uM after 15 to 60 mins in presence of CuSO4.5H2O2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID1871812Anticoagulant activity in rabbit plasma assessed as activated partial thromboplastin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID1323132Antioxidant activity assessed as DPPH free radical scavenging activity by measuring remaining DPPH at 5 uM after 15 to 60 mins relative to trolox2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID666770Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID510243Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID666768Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID353598Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.17 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]